ORPHA:314394
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome
Also known as: SOFT syndrome
Publications
2,744
Trials
0
Interventional, condition-specific
Researchers
1,071
Distinct authors in sample
Gene link
POC1A
Strong
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, primary bone disorder characterized by severe pre- and post-natal short stature, facial dysmorphism (incl.dolicocephaly, long triangular face, tall forehead, down-slanting palpebral fissures, prominent nose, long philtrum, small ears), early-onset or postpubertal sparse, short hair and hypoplastic fingernails. Small hands with tapering fingers, bracydactyly and fifth-finger clinodactyly, as well as a high-pitched voice are also associated.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0013894
- OMIM:614813
- UMLS:C3542022
Additional Mondo synonyms (1)
soft syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.
- Gene identifiedPresent
Strong — POC1A
- LiteraturePresent
2,744 matched papers (1,841 in last 10 years) Source
- Phenotype characterisedPresent
47 HPO annotations (e.g. Sparse hair; Macrocephaly; Microcephaly) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (POC1A).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
47
Associated phenotypes · MONDO:0013894
- Sparse hair
- Macrocephaly
- Microcephaly
- Small for gestational age
- Generalized hypotonia
Showing 5 of 47 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
2,744
2,744 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
2,744 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,841 in the last 10 years · low confidence
Phrase hits: 2,489 · MeSH hits: 0
Who's working on it?
1,071
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Zhang X10 papers · 2026
Department of General Dentistry, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, 210029, China.
Papers in Europe PMC - 02Li X7 papers · 2026
College of Food Science, Southwest University, Chongqing, China.
Papers in Europe PMC - 03Zhang H6 papers · 2026
School of Food and Biological Engineering, Jiangsu University, 301 Xuefu Road, Zhenjiang 212013, China. Electronic address: zhanghongyin126@126.com.
Papers in Europe PMC - 04Li J5 papers · 2025
From the The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology.
Papers in Europe PMC - 05Liu D5 papers · 2025
School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China; Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, 430065, China. Electronic address: liudahui@hbucm.edu.cn.
Papers in Europe PMC - 06Luo M5 papers · 2025
School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China; Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, 430065, China. Electronic address: lm19930312@163.com.
Papers in Europe PMC - 07Miao Y5 papers · 2025
School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China; Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, 430065, China. Electronic address: miaoyh@hbucm.edu.cn.
Papers in Europe PMC - 08Zhang J5 papers · 2026
Department of Orthopedics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Papers in Europe PMC - 09Zhao L5 papers · 2026
School of Food and Biological Engineering, Jiangsu University, 301 Xuefu Road, Zhenjiang 212013, China.
Papers in Europe PMC - 10Li L4 papers · 2026
Medical imaging department, Laizhou City People's Hospital, Laizhou, Shandong Province, 261400, People's Republic of China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 40 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 40 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (40)
- isrctn·ISRCTN14934633·Recruiting·Validation of clinical tests used in physiotherapy diagnostics
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14753723·Recruiting·A study to test the safety, tolerability and effect of ZI-MA4-1 for patients with locally advanced or metastatic solid malignancies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN96046168·No longer recruiting·Fascial manipulation and thoracolumbar pain
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN24846895·Recruiting·A study to explore the effect of immunotherapy drug, tebentafusp, on patients with clear cell sarcoma (ultra-rare, aggressive type of soft tissue sarcoma that primarily affects young adults)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10699447·No longer recruiting·A study of Pasritamig (JNJ-78278343) in combination with JNJ-86974680 for treatment of prostate cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN19551752·No longer recruiting·A clinical study on neck movement exercises for cervical spondylosis treatment
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17648638·No longer recruiting·Interventional rehabilitation for jaw joint problems
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN21010160·No longer recruiting·Bedside nose-to-intestine feeding with easily digested liquid nutrition for adults with acute respiratory distress and bleeding in the upper stomach or gut
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26415952·Recruiting·A Study to evaluate novel KarX and KarT Prototypes versus the KarXT and KarX-EC reference following single doses, and to explore the effect of food after multiple doses of selected prototypes in healthy adult participants
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN79162280·No longer recruiting·Impact of soft tissue techniques and neuromuscular re-education on patients with poor posture and related neck pain or knee osteoarthritis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16564696·Recruiting·The role of the carotid chemoreflex in long-COVID
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN75533638·Recruiting·CAR-T cells for children, teenagers and young adults with sarcoma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16221474·Recruiting·A study of JNJ-89853413 for relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasms
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11681307·No longer recruiting·The beneficial effect on gastrointestinal discomfort of a food supplement based on a mixture of tannins from Castanea sativa bark and Schinopsis quebracho-colorado wood
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18380042·No longer recruiting·Subacromial hyaluronic acid injections perform better when combined with exercise-based rehabilitation in the treatment of subacromial impingement syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN45695355·No longer recruiting·The beneficial effect on intestinal function of two dietary supplements, one based on resistant dextrin from wheat starch, fibers from citrus (pectin), and fibers from oat, one based on resistant dextrin from wheat starch, fibers from carob, and fibers from oat.
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN47182706·Recruiting·Investigating disruption of the local and systemic human immune response caused by recent Staphylococcus aureus skin infection
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN78231121·No longer recruiting·Testing 123I-ATT001, a new type of targeted radiotherapy, administered directly to the brain tumour of patients in whom the glioblastoma has returned after previous treatment
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16634513·Recruiting·Impact of a playful family education strategy with information and communication technology on childhood obesity prevention
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN87156139·Recruiting·Spinal manual therapy versus nerve root injection for patients with back-related leg pain
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36132797·No longer recruiting·Sleep position device versus continuous positive airway pressure in central sleep apnea
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN20833186·No longer recruiting·Comparative effectiveness of various treatment methods of masticatory myofascial pain
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10681798·No longer recruiting·A study to investigate the safety, tolerability, disposition in the body, effects of RO7308480 on the body, and its changes in midazolam disposition in the body following oral administration in healthy participants
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17378733·Recruiting·Assessing the use of tailored treatments based on combinations of genes that are active in a tumour, and the impact on outcomes for bladder cancer.
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14498712·No longer recruiting·Erdafitinib alone or in combination with cetrelimab as neoadjuvant treatment (prior to surgery) in subjects with muscle-invasive bladder cancer whose tumours express FGFR gene alterations and are ineligible for receiving cisplatin treatment
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome" OR "SOFT syndrome") OR ("POC1A" OR "POC1A syndrome" OR "POC1A-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome" OR "SOFT syndrome"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (2744) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T13:06:07.431Z
